drugset / Trial / NCT00473655

Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients

NCT00473655 ↗

Phase 4 Completed 334 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this trial is to determine if the treatment with rosuvastatin 10 and 20mg/day during 8 weeks in hypertriglyceridemic patients will reduce their triglyceride levels.

Timeline

Start
2007-01
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 10 mg —
Subject Rosuvastatin Small molecule 20 mg —